Interestingly, a recent report showed that compounds extracted from Chinese herbs could down-regulate DMT1 expression and up-regulate Fpn expression, thus providing a new strategy for reducing iron overload-induced impairment in AD (Dong et al., 2015). Here, SLC40A1 is linked to Alzheimer disease.